Liquid biopsies that analyse circulating tumour DNA (ctDNA) can give more information on the spatial and temporal heterogeneity of a tumour than traditional tissue genotyping. The use of liquid biopsy ctDNA assays in routine clinical practice requires careful attention to pre-analytical processing and the selection of the appropriate technology which may influence the results obtained. … Continued